This is a mechanism module, not a specific disease; do NOT create a "Germinal Center Reaction" Disease entry. Unlike most modules in kb/modules/, the process modelled here is normal physiology rather than a lesion, so the description does not open by calling itself a pathophysiology module; it follows innate_antiviral_interferon_response and host_directed_antiviral_dependency in naming the pathway directly. Disorder entries reference individual nodes via conforms_to (e.g. "germinal_center_reaction#Germinal Center Reaction"). The module defines the expected pathophysiology structure; conforming nodes should carry the corresponding cell types, biological processes, and causal edges, specialized to their disease context and directed with modifiers. Disorder-specific substitutions: an antibody-deficiency conformer substitutes its own molecular lesion for the generic step and reads the chain in the DECREASED or ABSENT direction (CVID at class switch recombination, APDS at B-cell maturation, Kabuki syndrome at somatic hypermutation, Specific Antibody Deficiency at the switched memory compartment, autosomal agammaglobulinemia at the humoral-immunity consequence, where the reaction never starts because no naive B cell reaches the follicle, Hyper-IgM syndrome type 2 at the reaction node itself, both processes read ABSENT because biallelic AICDA loss abolishes class switch recombination and somatic hypermutation together while germinal centers persist and enlarge, and X-linked agammaglobulinemia at the humoral-immunity consequence, the same shape as autosomal agammaglobulinemia since BTK loss arrests B-cell development at the pre-B stage before any cell reaches the follicle); a germinal-center-derived lymphoma substitutes the transformed clone and reads it in the dysregulated direction (Follicular_Lymphoma at the reaction node and at Tfh help). Selective IgA deficiency was assessed as a candidate conformer (issue #11897) and excluded: its defect is isotype-restricted (normal IgG and IgM by the disease's own case definition, where every declared conformer fails the reaction broadly) and its immunoglobulin heavy-chain alpha loci are structurally intact, so there is no lesion in this chain for it to substitute; the exclusion rationale is recorded on the entry itself. The terminal node, Clinical Susceptibility to Infection, was added later (issue #11907), and four modelling calls behind it are worth recording because none of them is forced. Its name is generic while the pathogen spectrum sits in its description: naming the spectrum, as the sibling phagocyte_oxidative_burst_failure node does, would have read the encapsulated-organism picture as the boundary of the node rather than its characteristic core, and X-linked_Agammaglobulinemia's disseminated enteroviral infection would then have had nowhere to conform. Its name is in the susceptibility direction although this module otherwise names nodes in the physiological direction, because the node carries no ontology-bound processes for a conformer's modifier to act on, and the protective statement is already made by Durable Protective Humoral Immunity immediately above it; the quantity that varies across conformers here is infection burden. No intermediate step was inserted between the two, because the evidence for the edge measures antibody level against infection incidence with nothing in between, and an intervening node would be unevidenced. It carries no GO, CL or UBERON binding, matching the sibling module's terminal node: the honest reading is that this is a clinical outcome rather than a host process, and it also keeps conformance cheap, since there is no expected process for a conformer to substitute. Four conformers declare against it — Hyper-IgM_Syndrome_Type_2, Autosomal_Agammaglobulinemia, Specific_Antibody_Deficiency and X-linked_Agammaglobulinemia — being the four that already carried an organism-level infection pathophysiology node. The rest (Common_Variable_Immunodeficiency, Activated_PI3K-delta_Syndrome, Kabuki_Syndrome, Immunodeficiency_102) run straight from a mechanism node to infection phenotypes with no pathophysiology node in between, so wiring them would mean creating a node rather than labelling one, and is left as per-entry curation. Explicitly out of scope, each to be argued as its own module: immunosenescence (upstream and age-driven, and the natural home for the poor-vaccine-response line inflammaging currently carries only as a model limitation); iatrogenic B-cell depletion (rituximab, transplant immunosuppression); asplenia and polysaccharide non-response, which run through T-independent antigens this chain does not cover; and waning immunity, which is plasma-cell survival kinetics rather than response failure. Vaccine effectiveness is deliberately not modelled as a module: it is the outcome of an intervention, and its failure modes do not share a causal chain — this module is the conserved process underneath the largest of them, and vaccine non-response is one readout of it rather than its definition (issue #10924). Mouse knockout data are used for the AID requirement and are graded MODEL_ORGANISM; the human requirement rests on the HIGM2 patient series. Immunoglobulin isotypes, AID chemistry, and BCL2 translocation are described in prose only; modules bind GO, CL, and UBERON terms and do not use gene (HGNC) or chemical (CHEBI) term bindings.
Antigen Capture and Naive B Cell Activation
trigger
Antigen draining into a secondary lymphoid organ is filtered and retained rather than passively diffusing through it: subcapsular sinus macrophages and follicular dendritic cells display intact, unprocessed antigen to B cells following defined migration paths through the follicle. A naive B cell whose receptor binds that antigen is activated, internalizes and processes it, and presents peptide on MHC class II, becoming competent to solicit T cell help. This is the entry point of the reaction; conformers whose B cells never reach the follicle (developmental arrest in bone marrow B lymphopoiesis) fail here by never starting.
Downstream
-
Cognate T Follicular Helper Cell Help
Show evidence (3 references)
"Multiple processes facilitate these encounters, from the filtering functions of lymphoid tissues and migration paths of B cells to the antigen-presenting properties of macrophages and follicular dendritic cells."
Names the components of this node: lymphoid-tissue antigen filtering, B cell migration through the follicle, and antigen display by macrophages and follicular dendritic cells. Evidence source is OTHER because this is a review.
"This Review will discuss how these factors work together in the lymph node to ensure efficient and persistent exposure of B cells to diverse forms of antigen and thus effective triggering of the humoral response."
Places the antigen-encounter step in the lymph node and identifies it as the trigger of the humoral response, supporting this node's role and anatomical location. Evidence source is OTHER because this is a review.
"Here, we review current understanding of how B cell responses are initiated; the different paths to generate short- and long-lived plasma cells, germinal center cells, and memory cells; and how each path impacts antibody diversity, selectivity, and affinity."
States that B cell response initiation is the upstream step of the paths that produce germinal center, plasma, and memory cells, establishing this node as the trigger of the chain the module models. Evidence source is OTHER because this is a review.
Cognate T Follicular Helper Cell Help
amplifier
An antigen-engaged B cell forms a cognate synapse with a CD4+ T cell that has differentiated along the Bcl6-dependent T follicular helper (Tfh) program. Tfh cells are the specialized CD4+ subset licensed to deliver follicular help, and their help is required both to nucleate a germinal center and to sustain the affinity-based selection that runs inside it. This node is the amplifier: a numerically small T cell population converts a single antigen-binding event into a self-sustaining, iteratively selected B cell reaction. Conformers substitute the specific lesion in T-B collaboration (costimulation, cytokine, or transcriptional) or, in germinal-center-derived lymphoma, a Tfh-containing supportive microenvironment that props up the transformed clone.
Show evidence (2 references)
"Helping B cells and antibody responses is a major function of CD4+ T cells."
Establishes that provision of help to B cells and their antibody responses is a principal CD4+ T cell function, the claim this node makes. Evidence source is OTHER because this is a review.
"the requirement of Tfh cells as the specialized subset of CD4+ T cells needed for germinal centers (the microanatomical sites of B cell mutation and antibody affinity maturation) and related B cell responses"
States that Tfh cells are the specialized CD4+ subset required for germinal centers, supporting both the Tfh differentiation binding on this node and its downstream edge to the germinal center reaction. Evidence source is OTHER because this is a review.
Germinal Center Reaction
central effector
Helped B cells seed a germinal center, a transient compartment within the follicle in which clonal expansion, AID-dependent somatic hypermutation of the immunoglobulin variable region, and class switch recombination proceed under iterative affinity-based selection. Mutation diversifies the receptor repertoire, selection retains the clones whose receptors bind antigen best, and switching changes the effector class of the antibody without changing its specificity. This is the rate-limiting, disorder-agnostic step every conformer funnels through and the module's key conformance target. Loss of AID abolishes both switching and hypermutation while leaving the germinal center itself enlarged, which is the cleanest demonstration that this node is a distinct mechanistic step rather than a synonym for germinal center formation. That AID argument licenses bundling somatic hypermutation with class switch recombination specifically; affinity-based selection is Tfh-driven light-zone biology and is mechanistically separable from AID-dependent mutation (CD40L and ICOS defects impair selection without touching AID). It is bundled here anyway because one rate-limiting conformance target is worth more to conformers than atomicity would be.
Downstream
-
Affinity-Matured Class-Switched B Cell Output
Show evidence (4 references)
"this structure is the site of B cell clonal expansion, somatic hypermutation, and affinity-based selection, the combination of which results in the production of high-affinity antibodies"
Names the three processes this node bundles — clonal expansion, somatic hypermutation, and affinity-based selection — and their output, high-affinity antibody. Evidence source is OTHER because this is a review.
"Germinal centers (GCs) are the site of antibody diversification and affinity maturation and as such are vitally important for humoral immunity."
Independently identifies the germinal center as the site of antibody diversification and affinity maturation and states its necessity for humoral immunity, supporting this node as the central effector of the chain. Evidence source is OTHER because this is a review.
"These results suggest that AID may be involved in regulation or catalysis of the DNA modification step of both class switching and somatic hypermutation."
Establishes in AID-deficient mice that a single enzyme is required for the DNA modification step of both class switch recombination and somatic hypermutation, which is why this node treats them as one rate-limiting step rather than two. Evidence source is MODEL_ORGANISM because the finding rests on AID-knockout mice and a B lymphoma line.
+ 1 more reference
Affinity-Matured Class-Switched B Cell Output
effector
Selected germinal center B cells exit as two durable populations: long-lived plasma cells that home to the bone marrow and secrete affinity-matured, class-switched antibody continuously, and memory B cells that persist without secreting and mount an accelerated response on re-encounter with antigen. These are functionally distinct outputs of the same reaction — one maintains a standing serum antibody titre, the other supplies recall capacity — and a conformer may lose either selectively, which is why the module keeps them in one node rather than collapsing them into the consequence below.
Downstream
-
Durable Protective Humoral Immunity
Show evidence (3 references)
"We found that the CD19(-)CD38(hi)CD138(+) subset was morphologically distinct, differentially expressed PC-associated genes, and exclusively contained PCs specific for viral antigens to which the subjects had not been exposed for more than 40 years."
Identifies a discrete human bone-marrow plasma cell subset carrying specificities from exposures decades earlier, establishing the long-lived plasma cell as a real, separable output of this node. Evidence source is HUMAN_CLINICAL because these are human bone-marrow donors.
"Recent advances in tracking antigen-experienced memory B cells have revealed the existence of distinct classes of cells that have considerable functional differences."
Establishes antigen-experienced memory B cells as a distinct, functionally heterogeneous output population alongside plasma cells, supporting the memory arm of this node. Evidence source is OTHER because this is a review.
"The phenotype observed in HIGM2 patients (and in AID-/- mice) demonstrates the absolute requirement for AID in several crucial steps of B cell terminal differentiation necessary for efficient antibody responses."
Connects the upstream germinal center node to this one: the AID-dependent step is required for the terminal B cell differentiation that produces efficient antibody responses, supporting the causal edge into this output node. Evidence source is HUMAN_CLINICAL because the claim is anchored on the HIGM2 patient phenotype.
Durable Protective Humoral Immunity
consequence
The standing serum and mucosal antibody maintained by long-lived plasma cells, together with the recall capacity held by memory B cells, constitutes durable protection against reinfection. This is the clinical consequence of the chain and the level at which it is measured: antibody titre and immune memory are the correlates of protection by which vaccines are judged, so vaccine non-response is one readout of this node rather than a mechanism of its own. Conformers read this node in the direction their disease takes it — absent in antibody deficiency, misdirected in autoantibody-mediated disease.
Downstream
-
Clinical Susceptibility to Infection
How much durable humoral immunity a person has sets how much infection they get. The relationship is graded rather than all-or-none, and moving the antibody level moves the infection rate, which is why this is a causal edge and not a restatement of the node above it.
Show evidence (3 references)
"Thus, our studies define human LLPCs and provide a mechanism for the life-long maintenance of anti-viral antibodies in the serum."
States the mechanism by which the upstream plasma cell output sustains serum antibody for life, which is the durability claim this consequence node makes. Evidence source is HUMAN_CLINICAL because this is a human bone-marrow study.
"Although the immune system is redundant, almost all current vaccines work through antibodies in serum or on mucosa that block infection or bacteremia/viremia and thus provide a correlate of protection."
Establishes serum and mucosal antibody as the protective mechanism and the measured correlate for nearly all vaccines, supporting this node as the protective endpoint of the chain and as the readout vaccine response is scored against. Evidence source is OTHER because this is a review.
"Immune memory is a critical correlate: effector memory for short-incubation diseases and central memory for long-incubation diseases."
Adds immune memory alongside antibody titre as a correlate of protection, supporting the memory B cell arm of the upstream node contributing to this consequence. Evidence source is OTHER because this is a review.
Clinical Susceptibility to Infection
outcome
Whether infection actually occurs, at the level of the whole organism. The node above is the immune state and is measured as antibody titre and recall capacity; this node is the clinical outcome and is measured as infection incidence, which is what the graded relationship between the two is established on. The characteristic spectrum of antibody-dependent susceptibility is recurrent sinopulmonary infection with encapsulated bacteria, and that spectrum is diagnostic enough to point at this arm of host defence rather than another. It is stated in this description rather than in the node name deliberately: it is the characteristic core and not the boundary, and conformers whose humoral failure is profound enough to add organisms outside it — disseminated enteroviral infection in agammaglobulinemia — conform here too. The specific organisms and organ distribution are disorder- and cohort-specific and should be evidenced locally rather than inherited from this node.
Show evidence (2 references)
"Recurrent sinopulmonary infections with encapsulated bacteria such as Haemophilus influenzae type B or Streptococcus pneumoniae may be characteristic of an antibody deficiency syndrome."
States the pathogen spectrum this node describes and, in the sentences around it, contrasts it with the spectra of T cell, phagocyte and complement defects — which is what makes the spectrum diagnostic of the humoral arm specifically. Graded HUMAN_CLINICAL because the clinical picture described is a human one; quote_role is REVIEW_SYNTHESIS because the citing publication is a review synthesizing it rather than reporting it.
"They most commonly present with recurrent infections due to encapsulated bacteria, although in the most common antibody deficiency, Common Variable Immunodeficiency, systemic and organ-specific autoimmunity can be a presenting feature."
Independent statement, across the primary antibody deficiency syndromes as a class rather than one disease, that recurrent encapsulated-organism infection is the usual presentation — the disorder-agnostic claim a module node has to make. Graded HUMAN_CLINICAL for the patient presentations described, with quote_role REVIEW_SYNTHESIS because this is a review.